Ultram and Iron dextran drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ultram (tramadol hydrochloride) and Iron dextran (iron dextran). Common drug interactions include amnesia among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Ultram and Iron dextran. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Ultram?
Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.
What is Iron dextran?
Iron dextran has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 1,487 Iron dextran users. Check the latest studies of Iron dextran.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
14 people who take Ultram and Iron dextran together, and have interactions are studied.

What are the common drug interactions of Ultram and Iron Dextran, by gender? *:
female:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Asthenia (weakness)
- Burning sensation
- Fatigue (feeling of tiredness)
- Gait disturbance
- Headache (pain in head)
- Hypoaesthesia (reduced sense of touch or sensation)
- Lymphoedema (localized fluid retention and tissue swelling)
- Muscle spasms (muscle contraction)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
male:
- Anxiety
- Arthralgia (joint pain)
- Headache (pain in head)
- Infection
- Lower respiratory tract infection
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Neutropenia (an abnormally low number of neutrophils)
- Oxygen saturation decreased
- Pneumonia
- Prostate cancer
What are the common drug interactions of Ultram and Iron Dextran, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anaemia (lack of blood)
- Arthralgia (joint pain)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Asthenia (weakness)
- Burning sensation
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Disturbance in attention
- Erythema (redness of the skin)
- Eye pain
50-59:
n/a
60+:
- Anxiety
- Arthralgia (joint pain)
- Headache (pain in head)
- Infection
- Lower respiratory tract infection
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Neutropenia (an abnormally low number of neutrophils)
- Oxygen saturation decreased
- Pneumonia
- Prostate cancer
What are the existing conditions these people have? *
- Spinal Pain (pain in spine): 5 people, 35.71%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 35.71%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 28.57%
- Pain In Extremity: 3 people, 21.43%
- Neck Pain: 3 people, 21.43%
- Muscle Spasms (muscle contraction): 3 people, 21.43%
- Lymphoedema (localized fluid retention and tissue swelling): 3 people, 21.43%
- High Blood Pressure: 3 people, 21.43%
- Back Pain: 3 people, 21.43%
- Breakthrough Pain: 2 people, 14.29%
* Approximation only. Some reports may have incomplete information.
Do you take Ultram and Iron dextran?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ultram (28,425 reports)
- Iron dextran (1,487 reports)
Browse all drug interactions of Ultram and Iron dextran:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ultram:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Iron dextran:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ultram and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Iron dextran and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
- Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on tramadol hydrochloride and iron dextran (the active ingredients of Ultram and Iron dextran, respectively), and Ultram and Iron dextran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Potassium Gluconate and Ginkgo Biloba - now
- Could Clopidogrel cause Localised Infection? - now
- Could Clopra cause Pupillary Reflex Impaired? - 5 seconds ago
- Could Requip cause Oral Infection? - 6 seconds ago
- Could Clopra cause Obsessive-Compulsive Disorder? - 6 seconds ago
- Drug interactions of Flecainide Acetate and Celecoxib - 8 seconds ago
- Could Requip cause Endometriosis? - 9 seconds ago
- Could Clopidogrel Bisulfate cause Gastric Ulcer? - 11 seconds ago
- Drug interactions of Grape Seed Extract and Hydramine - 13 seconds ago
- Could Remicade cause Weight Decreased? - 16 seconds ago